
Strut Health review
Right dose, wrong molecule
Publishes both the strength and the volume — 500 mg at 200 mg/mL — then describes NAD⁺ as a peptide that signals your pituitary gland.
Our verdict
Strut gets the hard part right and the easy part wrong. The dose is on the page, stated as 500 mg at 200 mg/mL, which puts it in the small group of sellers whose price you can actually convert into a cost per milligram. Directly underneath, the product bullets describe NAD⁺ as a peptide that signals your own pituitary gland and supports natural hormone production — a description of sermorelin, pasted onto a coenzyme it has nothing to do with. Buy on the numbers; ignore the three bullets under them.
Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- NAD⁺ injections
- Format
- Injection
- From
- $149
- Dose published
- Yes
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Labs
- Not stated
- LegitScript
- Claimed by provider
- Updated
- September 2026
Sponsored alternative
Care Bare Rx
Anyone who wants the price up front
Check Care Bare Rx availability →What it is
A long-running telehealth pharmacy brand with a wide compounded catalog — hair, skin, sexual health, sleep, weight, at-home lab panels — that sells NAD⁺ as a subcutaneous injection through separate men's and women's longevity pages.
How it works
A free online consultation comes first; Strut's disclaimer states that every prescription requires a complete online consultation before approval and that final pricing is determined at that point. Their NAD⁺ safety information is the most thorough in this batch — contraindications, drug interactions with niacin, cardiovascular and immunosuppressive medications, and a list of conditions that warrant extra monitoring. That page reads like it was written by a pharmacist rather than a marketer.
Pricing transparency
"Starting at $149", with no unit printed beside it. The same page carries a "less than $5/day" line, which points at a month, but the page never says so outright and the disclaimer adds that final pricing is set after the consultation. So treat $149 as an entry point rather than a bill. What makes it usable anyway is the dose next to it: 500 mg at 200 mg/mL, which is enough to compare against sellers charging similar money for an amount they will not disclose.
Branded vs compounded
Compounded NAD⁺, named as such in the ingredients line. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing. The route is stated as subcutaneous, and the safety page is explicit that it should not be injected any other way.
Pros and watch-outs
What we like
- Publishes strength and concentration — 500 mg at 200 mg/mL — alongside the price
- Entry price of $149, low for an injection at a stated dose
- Safety information that lists real contraindications and interactions rather than reassurance
- Free online consultation before anything is charged
- Displays a LegitScript seal
Watch-outs
- Describes NAD⁺ as "a peptide that signals your own pituitary gland" — that is sermorelin's mechanism, not NAD⁺'s
- The $149 carries no unit, and the disclaimer says final pricing is set after the consultation
- The compounding pharmacy is not named
- Separate men's and women's NAD⁺ pages carry effectively the same product, which makes the price harder to find than it should be
Best for
A buyer who wants a published milligram figure to judge the price against, and who reads the safety information rather than the product bullets.
Who should look elsewhere
Anyone who needs the final number before the consultation. Strut says openly that pricing is settled afterward.
How Strut Health compares
A few alternatives worth a look, depending on what you’re optimizing for.
- Care Bare Rx
Anyone who wants the price up front
See Care Bare Rx → - Breeze Meds
The lowest listed injection price
See Breeze Meds → - CoreAge Rx
The lowest published NAD⁺ price
See CoreAge Rx →
More NAD⁺ injection providers reviews: Wonderfeel YoungrProHealth LongevityDoNotAgeToniiq NAD+Nuform HealthTrava Health
Biochemistry & mechanism · Reviewed and last verified September 2026
How we assessed this. This review reflects NAD Picks’s own read of Strut Health’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- How much does Strut Health NAD⁺ cost?
- The page says "Starting at $149" for the NAD⁺ injection and does not attach a unit to it, though a "less than $5/day" line on the same page points at a month. Strut's own disclaimer adds that final pricing is determined after the online consultation, so the $149 is a starting point rather than a quote.
- What dose do you get?
- 500 mg at 200 mg/mL, printed directly under the price. That is a genuinely useful disclosure — most sellers of injectable NAD⁺ publish a monthly figure and no strength at all, which makes their price impossible to compare with anyone else's.
- Their page calls NAD⁺ a peptide that signals the pituitary. Is that right?
- No, and it is not a small slip. NAD⁺ is nicotinamide adenine dinucleotide, a coenzyme built from two nucleotides; it works inside cells in energy metabolism and as a substrate for enzymes like the sirtuins and PARPs. It does not act on the pituitary and it does not stimulate growth hormone release. That description belongs to sermorelin, a different product in the same catalog.
- Is a subcutaneous injection the right route?
- It is the route Strut prescribes, and their safety page says explicitly not to use any other. Whether the route matters clinically is unsettled: there is no controlled human outcome trial comparing subcutaneous NAD⁺ with intramuscular, intranasal or intravenous, and none showing any of them produces the results the category is marketed on.